Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease
Document Type
Letter to the Editor
Publication Date
7-7-2021
Publication Title
Neurology
Volume
97
Issue
11
First page number:
543
Last page number:
544
Disciplines
Clinical Trials | Medical Pharmacology
Language
English
Rights
IN COPYRIGHT. For more information about this rights statement, please visit http://rightsstatements.org/vocab/InC/1.0/
Repository Citation
Salloway, S.,
Cummings, J.
(2021).
Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease.
Neurology, 97(11),
543-544.
http://dx.doi.org/10.1212/WNL.0000000000012451